The 2026 Breakthrough Prizes — often called the “Oscars of Science” — have been awarded, and this year's winners include researchers whose work is nothing short of miraculous: curing inherited blindness, sickle cell disease, and beta-thalassemia through gene therapy.
The Winners
Six prizes of $3 million each were awarded on April 18, 2026, in Los Angeles. The Life Sciences prizes went to:
- Jean Bennett, Katherine A. High, and Albert Maguire — for developing Luxturna, the first FDA-approved gene therapy for inherited retinal disease. Children who were going blind can now see.
- Stuart H. Orkin and Swee Lay Thein — for discoveries that led to CRISPR-based gene editing therapies for sickle cell disease and beta-thalassemia. Their work identified the BCL11A gene as a key target, enabling treatments that are effectively curing these devastating blood disorders.
- Rosa Rademakers and Bryan Traynor — for identifying a major genetic cause of ALS (motor neurone disease) and frontotemporal dementia, opening doors to future treatments.
From 'It Will Never Work' to Nobel-Level Impact
Many of these researchers spent decades pursuing gene therapy when the scientific establishment dismissed it as impossible. “I can't tell you how many times people said it will never work,” one laureate told reporters.
Their persistence has paid off spectacularly. Luxturna has restored sight to children with inherited blindness. The CRISPR-based therapy Casgevy — built on Orkin and Thein's foundational work — is now approved in multiple countries and producing what doctors describe as functional cures for sickle cell disease.
Why This Matters
Sickle cell disease affects an estimated 20 million people worldwide, predominantly in Africa and among people of African descent. Beta-thalassemia affects millions more across the Mediterranean, Middle East, and Asia. These are not niche conditions — they are among the most common genetic diseases on Earth.
The fact that we now have functional cures for some of these conditions — and are rapidly developing more — represents one of the greatest medical achievements of our era.
This year's total prize money reached $18.75 million, bringing the Breakthrough Prize's lifetime total to over $340 million invested in celebrating scientific excellence.
Sources: Breakthrough Prize Foundation, The Scientist, IFLScience, Global Genes (April 18, 2026)
